APXH Two Roads Shared Trust - APEX HealthCare ETF
Quote as of Jan 24, 2023 20:02 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 8.88 | Day Range | 8.84 – 8.87 |
| 52-Week Range | 7.75 – 9.62 | Volume | 518 |
| Avg Volume | — | AUM | — |
| Expense Ratio | — | Yield (TTM) | — |
| NAV | — | Premium/Discount | — |
| Inception | — | Holdings | — |
| Issuer | — | Exchange | CBOE |
| Category | — | Index Tracked | Not stated in source data |
| CUSIP | — | ISIN | — |
| Management | Not stated in source data | ||
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | -0.45% | +6.40% | +1.02% | +0.80% | -1.82% | — | — | — | -12.70% |
| Total return | -0.45% | +6.74% | +1.26% | +0.80% | -1.55% | — | — | — | -12.44% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Jan 24, 2023. Past performance does not guarantee future results.
Fees
| Net expense ratio | — | Annual cost of a $10,000 investment | — |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Apr 17, 2023 — portfolio reporting date from the data provider; holdings are not live positions. 72 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | ISHARES GLOBAL HEALTHCARE | IXJ | 8.78% | 246 | $0.00 |
| 2 | THERMO FISHER | TMO | 5.40% | 22 | $0.00 |
| 3 | NOVO NORDISK-B | NOVOB | 5.22% | 125 | $0.00 |
| 4 | JOHNSON&JOHNSON | JNJ | 5.15% | 75 | $0.00 |
| 5 | PFIZER INC | PFE | 5.12% | 280 | $0.00 |
| 6 | INTUITIVE SURGIC | ISRG | 5.02% | 36 | $0.00 |
| 7 | DANAHER CORP | DHR | 5.02% | 39 | $0.00 |
| 8 | ABBOTT LABS | ABT | 4.93% | 99 | $0.00 |
| 9 | EDWARDS LIFE | EW | 4.82% | 105 | $0.00 |
| 10 | BIONTECH SE | BNTX | 4.08% | 38 | $0.00 |
| 11 | REGENERON PHARM | REGN | 3.83% | 16 | $0.00 |
| 12 | HOYA CORP | 7741 | 3.33% | 52 | $0.00 |
| 13 | VERTEX PHARM | VRTX | 3.06% | 40 | $0.00 |
| 14 | AGILENT TECH INC | A | 3.02% | 46 | $0.00 |
| 15 | SEAGEN INC | SGEN | 2.09% | 28 | $0.00 |
| 16 | WEST PHARMACEUT | WST | 1.94% | 11 | $0.00 |
| 17 | LABORATORY CP | LH | 1.78% | 15 | $0.00 |
| 18 | US DOLLARS | — | 1.72% | 3.98K | $0.00 |
| 19 | CHUGAI PHARMA CO | 4519 | 1.47% | 91 | $0.00 |
| 20 | WATERS CORP | WAT | 1.35% | 9 | $0.00 |
| 21 | BIO-RAD LABS-A | BIO | 1.26% | 4 | $0.00 |
| 22 | PERKINELMER INC | PKI | 1.25% | 17 | $0.00 |
| 23 | COOPER COS INC | COO | 1.23% | 7 | $0.00 |
| 24 | HOLOGIC INC | HOLX | 1.16% | 38 | $0.00 |
| 25 | QUEST DIAGNOSTIC | DGX | 1.10% | 18 | $0.00 |
Click a ticker to see every ETF that owns it.
Distributions
| Yield (TTM) | — | Paid (last 12 months) | — |
| Frequency | Irregular | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Dec 15, 2022 | Last payment | $0.0270 (Dec 21, 2022) |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Dec 15, 2022 | Dec 16, 2022 | Dec 21, 2022 | $0.0270 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
Liquidity
| Volume today | 518 | Average volume | — |
| AUM | — | Premium/Discount | — |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing. No official links available from our data source for this fund yet.
Latest News for APXH
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.